Create Free Account

By creating account you will get access to hot stocks & personalised emails

Neuren Pharmaceuticals Ltd

Healthcare AU NEU

14.55AUD
0.54(3.85%)

Last update at 2025-01-23T05:10:00Z

Day Range

14.0214.57
LowHigh

52 Week Range

10.9024.25
LowHigh

Fundamentals

  • Previous Close 14.01
  • Market Cap1586.81M
  • Volume692696
  • P/E Ratio11.96
  • Dividend Yield-%
  • EBITDA155.19M
  • Revenue TTM193.34M
  • Revenue Per Share TTM1.51
  • Gross Profit TTM 160.44M
  • Diluted EPS TTM1.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 0.18M -7.79400M -9.19300M -10.81600M 3.07M
Minority interest - - - - -
Net income 2.37M -7.74500M -9.04000M -10.42300M 3.07M
Selling general administrative 3.44M 1.91M 1.76M 1.71M 2.07M
Selling and marketing expenses - - - - -
Gross profit 14.55M - - -9.36300M 7.89M
Reconciled depreciation 0.01000M 0.00800M 0.00600M 0.00400M 0.08M
Ebit -1.60600M -11.43800M -9.53200M -11.57500M 3.07M
Ebitda -1.59600M -11.43000M -9.52600M -11.57100M 3.15M
Depreciation and amortization 0.01000M 0.00800M 0.00600M 0.00400M 0.08M
Non operating income net other - - - - -
Operating income -1.60600M -11.43800M -9.53200M -11.57500M -8.25300M
Other operating expenses 16.16M 11.44M 9.53M 11.57M -
Interest expense 0.39M 3.64M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.39M 0.40M 0.15M 0.13M 2.96M
Net interest income 0.39M 0.04M 0.15M 0.39M 0.22M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -2.18100M -0.04900M -0.15300M -0.39300M 0.00000M
Total revenue 14.55M 0.04M 0.15M 0.39M 13.76M
Total operating expenses 16.16M 11.44M 9.53M 11.57M 8.25M
Cost of revenue - - - 9.86M 6.10M
Total other income expense net 1.79M 3.64M 0.34M 0.76M 11.33M
Discontinued operations - - - - -
Net income from continuing ops 0.18M -7.79400M -9.19300M -10.81600M 3.07M
Net income applicable to common shares 0.18M -7.79400M -9.19300M -10.81600M 3.07M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 247.97M 43.27M 40.06M 24.95M 14.41M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets 4.21M 1.98M 1.84M - 0.00000M
Total liab 42.76M 1.68M 0.80M 0.75M 0.56M
Total stockholder equity 205.21M 41.59M 39.25M 24.20M 13.85M
Deferred long term liab - - - - -
Other current liab 42.09M 1.42M 0.56M 0.59M 0.22M
Common stock 173.13M 167.74M 167.58M 145.57M 126.43M
Capital stock 173.13M 167.74M 167.58M 145.57M 126.43M
Retained earnings 38.39M -118.69300M -118.87700M -111.08300M -104.07600M
Other liab - - - - -
Good will - - - - -
Other assets 0.00000M - - - -
Cash 17.09M 40.18M 36.78M 24.19M 13.84M
Cash and equivalents - 37.88M 29.87M 23.96M 13.02M
Total current liabilities 42.76M 1.68M 0.80M 0.75M 0.56M
Current deferred revenue - - - - -
Net debt -17.09400M -40.18000M -36.78300M -24.18800M -13.84400M
Short term debt - 0.00000M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -